Dominic Martin Etienne Page
Direttore/Membro del Consiglio presso Abcam (US) Ltd.
Posizioni attive di Dominic Martin Etienne Page
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Abcam (US) Ltd.
 Abcam (US) Ltd. Financial ConglomeratesFinance Part of Abcam Plc, Abcam (US) Ltd. functions as an investment holding British company. The company is based in Cambridge, UK and was founded in 2012. | Direttore/Membro del Consiglio | 26/03/2019 | - |
Firefly BioWorks, Inc.
 Firefly BioWorks, Inc. Medical SpecialtiesHealth Technology Firefly BioWorks, Inc. develops an open platform allowing industrial, academic and clinical scientists to develop and use multiplexed assays on standard laboratory instrumentation. It offers Multiplex Cellular miRNA and Multiplex Circulating miRNA Assays that use Firefly particle technology to enable simultaneous analysis of 68 miRNAs per well; and vacuum manifold for 96 well filter plates. The company was founded by Davide M. Marini and Daniel C. Pregibon in 2009 and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | - | - |
| Treasurer | - | - |
Storia della carriera di Dominic Martin Etienne Page
Statistiche
Distribuzione geografica
| Regno Unito | 2 |
| Stati Uniti | 2 |
Posizioni
| Director/Board Member | 2 |
| Treasurer | 1 |
Settori
| Finance | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Abcam (US) Ltd.
Abcam (US) Ltd. Financial ConglomeratesFinance Part of Abcam Plc, Abcam (US) Ltd. functions as an investment holding British company. The company is based in Cambridge, UK and was founded in 2012. | Finance |
Firefly BioWorks, Inc.
Firefly BioWorks, Inc. Medical SpecialtiesHealth Technology Firefly BioWorks, Inc. develops an open platform allowing industrial, academic and clinical scientists to develop and use multiplexed assays on standard laboratory instrumentation. It offers Multiplex Cellular miRNA and Multiplex Circulating miRNA Assays that use Firefly particle technology to enable simultaneous analysis of 68 miRNAs per well; and vacuum manifold for 96 well filter plates. The company was founded by Davide M. Marini and Daniel C. Pregibon in 2009 and is headquartered in Cambridge, MA. | Health Technology |
